SM Fragomeni, A Sciallis… - Surgical Oncology …, 2018 - surgonc.theclinics.com
Breast cancer is a heterogeneous disease that affects one anatomic site, yet is phenotypically variable. 1, 2 The identification of different biological subtypes occurs …
O Yersal, S Barutca - World journal of clinical oncology, 2014 - ncbi.nlm.nih.gov
Breast cancer is a heterogeneous complex of diseases, a spectrum of many subtypes with distinct biological features that lead to differences in response patterns to various treatment …
HG Russnes, OC Lingjærde, AL Børresen-Dale… - The American journal of …, 2017 - Elsevier
Breast carcinomas can be stratified into different entities based on clinical behavior, histologic features, and/or by biological properties. A classification of breast cancer should …
Tumors develop multiple mechanisms of immune evasion as they progress, with some cancer types being inherently better at 'hiding'than others. With an increased understanding …
N Eliyatkın, E Yalçın, B Zengel, S Aktaş… - The journal of breast …, 2015 - ncbi.nlm.nih.gov
Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and molecular properties. Traditional classification use morphology to divide tumors into …
The last decade has brought a breakthrough in the knowledge of the biology of breast cancer. The technological development, and in particular the high throughput technologies …
G Bianchini, JM Balko, IA Mayer, ME Sanders… - Nature reviews Clinical …, 2016 - nature.com
Chemotherapy is the primary established systemic treatment for patients with triple-negative breast cancer (TNBC) in both the early and advanced-stages of the disease. The lack of …
It has recently become clear that the tumour microenvironment, and in particular the immune system, has a crucial role in modulating tumour progression and response to therapy …
The immunosurveillance theory postulates that tumors evolve and progress in an uncontrolled fashion only when anticancer immune responses fail. Natural …